Purpura caused by refers to purple or reddish skin discolorations resulting from blood leaking into tissues beneath the skin, typically due to low platelet counts, damaged blood vessels, or impaired clotting mechanisms. These lesions do not fade under pressure and are distinct from bruises caused by trauma.
Purpura appears when small blood vessels (capillaries) rupture or become abnormally permeable. The color ranges purple depending on the age of the bleed. Unlike bruises, which result from external injury, purpura often arises internally and may indicate an underlying medical condition requiring evaluation.
Common causes include thrombocytopenia (low platelets), vasculitis (inflammation of blood vessels), coagulopathy (clotting factor deficiencies), and medication side effects. Identifying the cause requires clinical assessment, lab tests, and sometimes biopsy.
Blood normally stays within vessels due to intact endothelial linings and functional platelets. When either fails, red blood cells escape into surrounding tissue. As they break down, hemoglobin releases iron, producing the characteristic blue-purple hue.
Platelets are essential for sealing small tears. A count below 100,000 per microliter increases risk. Below 20,000, spontaneous purpura becomes likely. In severe cases, even minor pressure can trigger bleeding.
Vasculitis damages vessel walls directly. Immune complexes deposit in capillaries, triggering inflammation and rupture. This mechanism explains purpura in conditions like Henoch-Schönlein purpura, which affects children and presents with palpable skin lesions on legs and buttocks.
The appearance and distribution of purpura help distinguish among causes. Table below outlines key categories based on pathophysiology and clinical features.
| Type | Primary Mechanism | Typical Location | Associated Conditions |
|---|---|---|---|
| Thrombocytopenic | Low platelet count | Extremities, trunk | Immune thrombocytopenia (ITP), leukemia, heparin-induced thrombocytopenia (HIT) |
| Non-thrombocytopenic (vasculitic) | Vessel wall inflammation | Lower limbs, buttocks | Henoch-Schönlein purpura, systemic lupus erythematosus (SLE), drug reactions |
| Coagulopathy-related | Deficient clotting factors | Anywhere, often with joint or mucosal bleeding | Hemophilia A/B, vitamin K deficiency, liver disease |
| Drug-induced | Medication-triggered platelet dysfunction or vascular damage | Variable | Aspirin, NSAIDs, clopidogrel, quinine |
Not all purpura is the same. Petechiae are pinpoint spots (<2 mm), while ecchymoses are larger patches (>1 cm). Purpura is generally defined as lesions between 3 mm and 10 mm in diameter.
A non-obvious distinction: purpura from vasculitis often feels firm or raised, whereas thrombocytopenic purpura is flat and fades slowly. This tactile difference aids early clinical differentiation.
Purpura is frequently mistaken for bruising from injury. However, bruising results from mechanical force. Purpura occurs without trauma and may appear in areas not subject to impact.
Another error is assuming all purpura stems from low platelets. While thrombocytopenia is common, many patients with normal platelet counts still develop purpura due to vascular fragility or immune-mediated damage.
For example, a 12-year-old boy presented with symmetrical leg purpura, abdominal pain, and joint swelling. Initial concern was trauma. But absence of injury history and presence of palpable lesions led to diagnosis of Henoch-Schönlein purpura-a form of IgA vasculitis. His platelet count was normal, ruling out thrombocytopenia.
When purpura is identified, clinicians assess for systemic symptoms such as fever, joint pain, or kidney involvement. Blood tests including complete blood count (CBC), prothrombin time (PT), partial thromboplastin time (aPTT), and platelet function assays are standard.
If vasculitis is suspected, a skin biopsy may show fibrinoid necrosis and neutrophil infiltration around vessels. Immunofluorescence can detect immune deposits in the vessel wall.
According to the American Society of Hematology, about 60% of adult patients with unexplained purpura have a hematologic disorder. In children, Henoch-Schönlein purpura accounts for nearly half of non-traumatic cases.
A 68-year-old woman on long-term aspirin therapy for coronary artery disease developed new purpura on her arms and legs. She denied recent trauma. Physical exam revealed non-blanching lesions averaging 5 mm in size.
Laboratory workup showed normal platelet count (220,000/µL), normal PT/aPTT, and no signs of infection. Given her aspirin use, the cause was attributed to platelet inhibition. Discontinuation of aspirin led to resolution of lesions over 7 days.
This case illustrates that purpura caused by medication-especially antiplatelets-is reversible upon withdrawal. It also shows that normal lab values don't rule out drug-induced purpura.
Purpura caused by is not a single disease but a sign of multiple underlying processes. Accurate identification requires distinguishing between thrombocytopenic, vasculitic, coagulopathic, and drug-induced forms. Early recognition prevents complications such as internal hemorrhage or organ damage.
Understanding what is purpura caused by begins with recognizing that skin changes are signals-not diagnoses. Always pursue the cause through history, physical exam, and targeted testing.